Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Teva May Have To Forfeit Exclusivity For Hyzaar/Cozaar Generics

Executive Summary

FDA's recent wave of decisions outlining when generic firms forfeit their 180-day exclusivity appears destined to wipe out one of Teva's most prized possessions: exclusivity for Merck's Hyzaar and Cozaar

You may also be interested in...



ANDA Exclusivity Protected From Patent Delisting Under Appeals Court Ruling

Generic companies will no longer lose 180-day marketing exclusivity solely because a brand name company delists a patent they have challenged

ANDA Exclusivity Protected From Patent Delisting Under Appeals Court Ruling

Generic companies will no longer lose 180-day marketing exclusivity solely because a brand name company delists a patent they have challenged

The Shadow Of 2003: Hatch/Waxman Changes May Join Health Reform Bills

The Medicare drug benefit, created in 2003, is casting a long shadow on the health care reform debate of 2009

Related Content

UsernamePublicRestriction

Register

LL1125120

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel